147 CD155 blockade boosts alloreactive natural killer cell antitumor effects against osteosarcoma
Sign Up to like & getrecommendations! Published in 2020 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2020-sitc2020.0147
Abstract: Background Pediatric patients with relapsed and refractory osteosarcoma have poor prognoses with few treatment options. Allogeneic bone marrow transplant (BMT) has not yet shown a graft-versus-tumor (GVT) effect for osteosarcoma. Natural killer (NK) cells demonstrate… read more here.
Keywords: blockade; cd155; natural killer; cd155 blockade ... See more keywords